Articles

Pharmaceutical marketing research and data analytics companies should not be required to assume responsibility for formal reporting of adverse events (AEs) uncovered during routine pharmaceutical marketing research and data analytics in the U.S. because:

Effective October 1, 2006, information services are subject to New Jersey sales and use tax.

"In your letter, you ask various questions concerning access to the National Do Not Call Registry by members of the market or opinion research industry."